Epigenetics: A new link between nutrition and cancer
1/13/2014
In "Epigenetics: A New Link Between Nutrition and Cancer", a recent article from Nutrition and Cancer: An International Journal, a publication of Routledge, researchers explore the possible effects that diet can have on gene expression through epigenetic mechanisms.
Fully automated venipuncture device can improve paediatric experience
1/13/2014
A new medical device has been developed that will provide phlebotomists and clinicians with a technology to enable blood drawing accuracy at first stick. This is particularly important considering the diverse patient demographic each with various levels of difficult venous access. Soon, this enhanced accuracy will greatly reduce patient discomfort as well as procedure time and cost.
BerGenBio presents data at AACR-ISLAC conference on the molecular origins of lung cancer
1/13/2014
BerGenBio AS, an oncology biopharmaceutical company, announces that preclinical data demonstrating that its lead compound, BGB324 has potential application as a novel treatment for non-small cell lung cancer (NSCLC) was presented in a poster at the American Association of Cancer Research and The International Association for the Study of Lung Cancer's (AACR-ISLAC) joint conference on the...
A tumor suppressor gene discovered in a very aggressive lung cancer
1/13/2014
The Genes and Cancer Group at the Cancer Epigenetics and Biology Program of the IDIBELL has found that the MAX gene, which encodes a partner of the MYC oncogene, is genetically inactivated in small cell lung cancer. Reconstitution of MAX significantly reduced cell growth in the MAX-deficient cancer cell lines.
A tumor suppressor gene discovered in a very aggressive lung cancer
1/13/2014
The Genes and Cancer Group at the Cancer Epigenetics and Biology Program of the IDIBELL has found that the MAX gene, which encodes a partner of the MYC oncogene, is genetically inactivated in small cell lung cancer. Reconstitution of MAX significantly reduced cell growth in the MAX-deficient cancer cell lines.
Ovarian cancer biomarker discovered
1/13/2014
Researchers at Case Western Reserve University have identified a microRNA biomarker that shows promise in predicting treatment response in the most common form of ovarian cancer - a breakthrough that has the potential to improve outcomes for patients with the disease.
Score that combines genetic and epigenetic changes might help guide acute myeloid leukemia therapy
1/13/2014
Currently, doctors use chromosome markers and gene mutations to determine the best treatment for a patient with acute myeloid leukemia (AML). But a new study suggests that a score based on seven mutated genes and the epigenetic changes that the researchers discovered were present might help guide treatment by identifying novel subsets of patients.
Type 1 diabetes in mice averted with cancer drug
1/13/2014
A new international study led by the University of Copenhagen in Denmark has taken a significant step toward the prevention of type 1 diabetes, by showing how low doses of a cancer drug stopped it developing in disease-prone mice.The treatment also protected the insulin-producing cells in the pancreas from being destroyed.Dr.
Patients with head and neck cancer who are treated with an advanced form of radiation therapy may experience fewer side effects and be less likely to die from their disease than patients who receive standard radiation therapy. That is the finding of an analysis published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
Potential new blood test to locate gene defects associated with cancer
1/13/2014
Some surprising research findings from scientists at The University of Texas MD Anderson Cancer Center suggest it's possible a simple blood test could be developed to determine whether gene mutations associated with pancreatic cancer exist without the need of locating and testing tumor tissue.